These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11425561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide.
    Casini A, Scozzafava A, Mincione F, Menabuoni L, Starnotti M, Supuran CT.
    Bioorg Med Chem Lett; 2003 Sep 01; 13(17):2867-73. PubMed ID: 14611846
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.
    Renzi G, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2000 Apr 03; 10(7):673-6. PubMed ID: 10762051
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors: sulfonamides incorporating furan-, thiophene- and pyrrole-carboxamido groups possess strong topical intraocular pressure lowering properties as aqueous suspensions.
    Ilies M, Supuran CT, Scozzafava A, Casini A, Mincione F, Menabuoni L, Caproiu MT, Maganu M, Banciu MD.
    Bioorg Med Chem; 2000 Aug 03; 8(8):2145-55. PubMed ID: 11003159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors. Part 79. Synthesis of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure-lowering properties.
    Mincione G, Menabuoni L, Briganti F, Mincione F, Scozzafava A, Supuran CT.
    Eur J Pharm Sci; 1999 Dec 03; 9(2):185-99. PubMed ID: 10620731
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: synthesis and inhibition against isozymes I, II and IV of topically acting antiglaucoma sulfonamides incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido moieties.
    Casini A, Mincione F, Ilies MA, Menabuoni L, Scozzafava A, Supuran CT.
    J Enzyme Inhib; 2001 Dec 03; 16(2):113-23. PubMed ID: 11342280
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors. Synthesis of topically effective intraocular pressure lowering agents derived from 5-(omega-aminoalkylcarboxamido)-1,3,4-thiadiazole-2-sulfonamide.
    Barboiu M, Supuran CT, Menabuoni L, Scozzafava A, Mincione F, Briganti F, Mincione G.
    J Enzyme Inhib; 2000 Dec 03; 15(1):23-46. PubMed ID: 10850953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.